Lv5
914 积分 2022-06-12 加入
Advancing Poly (ADP-ribose) Polymerase Inhibition Strategies Beyond BRCA1/2 in Prostate Cancer
8个月前
已关闭
Stereotactic ablative body radiotherapy for PSMA-PET/CT staged, oligometastatic prostate cancer - A multi-centre study
9个月前
已完结
Direct Treatment of All Visible Tumour in Synchronous Oligometastatic Prostate Cancer: Total Eradication of Tumour or the Full Monty Treatment
9个月前
已完结
A Phase 2 Trial of Radium223 and Stereotactic Ablative Radiation Therapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR Study
9个月前
已完结
Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer
9个月前
已完结
Prostatectomy and other local treatments for oligometastatic prostate cancer: recent and ongoing trials
9个月前
已完结
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway)
11个月前
已完结
Time to Castration Resistance is Associated With Overall Survival Even After the Achievement of Castration Resistance in Metastatic Prostate Cancer
11个月前
已关闭
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer
1年前
已完结
皖公网安备34019202002308
